5 hours ago
Based on 8 major questions and consisting of 9 formal recommendations, the SCAI’s guidelines aim to advise clinicians on what treatments to use when.
9 hours ago
Q2 2025 saw new therapies approved for a number of rare disease indications, multiple of which serve as the first disease-modifying therapies in the landscape.
14 hours ago
Following the AAD guideline update on atopic dermatitis treatments, Sidbury speaks to the significance of the guideline recommendations for patients and clinicians.
July 05, 2025
Key FDA approvals, clinical trial insights, and expert commentary in allergy care from the first half of 2025.
July 05, 2025
The Q2 recap for nephrology spotlights key FDA decisions and top coverage from the 62nd European Renal Association Congress.